Ruth Beadle, head, global supply chain, Sanofi, explains how the company balances daily operations with long-term ...

In the first part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while also providing a framework for data-driven drug repurposing.

Andrew Witty resigns due to personal reasons, as Stephen Hemsley, chairman and former chief executive, will assume the ...

Similar to tariffs in which Trump felt that the United States was not treated fairly when it came to be taxed on certain ...

In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

In the third part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

The financial decision is due to customer demand stemming from the reshoring of drug supply services.

In the second part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ senior director of DSCSA/serialization ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

A multi-national study reveals over half of older adults in several European countries are prescribed five or more ...

Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement challenges, shifting distribution models, and expanding the drugs’ potential into ...